Targeting docetaxel-PLA nanoparticles simultaneously inhibit tumor growth and liver metastases of small cell lung cancer

International Journal of Pharmaceutics

Volumn 494, Issue 1, 2015, Pages 337-345

  Liang, Zhen ^a   Yang, Nan ^a   Jiang, Yao ^a   Hou, Chunying ^a   Zheng, Ji ^a   Shi, Jiaojiao ^a   Zhang, Rui ^a   Li, Dongmei ^a   Liu, Yanyong ^a   Zuo, Pingping ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Docetaxel (DTX); Nanoparticles; Small cell lung cancer (SCLC); Targeting peptide

Indexed keywords

DOCETAXEL; NANOPARTICLE; POLYLACTIC ACID; ANTINEOPLASTIC AGENT; DRUG CARRIER; LACTIC ACID; POLYMER; TAXOID;

A549 CELL LINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER THERAPY; CELL ENCAPSULATION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG TARGETING; DRUG TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGE DISPLAY; POLYMERIZATION; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; SUSTAINED DRUG RELEASE; TUMOR GROWTH; TUMOR VOLUME; ANIMAL; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; HUMAN; LIVER NEOPLASMS; LUNG NEOPLASMS; PATHOLOGY; SECONDARY; SMALL CELL LUNG CARCINOMA; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LACTIC ACID; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; NANOPARTICLES; PARTICLE SIZE; POLYMERS; SMALL CELL LUNG CARCINOMA; TAXOIDS;

EID: 84940028570     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.08.042     Document Type: Article

References (35)

1. S. Cascinu, F. Graziano, S. Barni, R. Labianca, G. Comella, R. Casaretti, L. Frontini, V. Catalano, A.M. Baldelli, and G. Catalano A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer Br. J. Cancer 84 2001 470 474 10.1054/bjoc.2000.1631
2. Y. Dong, and S.-S. Feng Poly(D,L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs Biomaterials 26 2005 6068 6076 10.1016/j
3. B. Du, H. Han, Z. Wang, L. Kuang, L. Wang, L. Yu, M. Wu, Z. Zhou, and M. Qian targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide Mol. Cancer. Res. 8 2010 135 144 10.1158/1541-7786
4. A. Friedler, B.S. DeDecker, S.M.V. Freund, C. Blair, S. Rüdiger, and A.R. Fersht Structural distortion of p53 by the mutation R249S and its rescue by a designed peptide: implications for mutant conformation J. Mol. Biol. 336 2004 187 196
5. C.W. Gan, and S.-S. Feng Transferrin-conjugated nanoparticles of poly(lactide)-D-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier Biomaterials 31 2010 7748 7757 10.1016/j
6. H. Gao, Z. Yang, S. Zhang, S. Cao, S. Shen, Z. Pang, and X. Jiang Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization Sci. Rep. 3 2013 10.1038/srep02534
7. F. Gueritte-Voegelein, D. Guenard, F. Lavelle, M.T. Le Goff, L. Mangatal, and P. Potier Relationships between the structure of taxol analogs and their antimitotic activity J. Med. Chem. 34 1991 992 998 10.1021/jm00107a017
8. T. Hoang, and D.J.H. Schiller Systemic treatment of small cell lung cancer Am. J. Cancer 1 2012 397 408 10.2165/00024669-200201060-00003
9. H.-Y. Hwang, I.-S. Kim, I.C. Kwon, and Y.-H. Kim Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles J. Control. Release 128 2008 23 31 10.1016/j
10. D.M. Jackman, and B.E. Johnson Small-cell lung cancer Lancet 366 2005 1385 1396
11. G.P. Kalemkerian, W. Akerley, P. Bogner, H. Borghaei, L.Q. Chow, R.J. Downey, L. Gandhi, A.K.P. Ganti, R. Govindan, J.C. Grecula, J. Hayman, R.S. Heist, L. Horn, T. Jahan, M. Koczywas, B.W. Loo, R.E. Merritt, C.A. Moran, H.B. Niell, J. O'Malley, J.D. Patel, N. Ready, C.M. Rudin, C.C. Williams, K. Gregory, M. Hughes, and National Comprehensive Cancer Network Small cell lung cancer J. Natl. Compr. Cancer Netw. 11 2013 78 98
12. J.-H. Kim, Y.-S. Kim, K. Park, S. Lee, H.Y. Nam, K.H. Min, H.G. Jo, J.H. Park, K. Choi, S.Y. Jeong, R.-W. Park, I.-S. Kim, K. Kim, and I.C. Kwon Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice J. Control. Release 127 2008 41 49 10.1016/j
13. M.N. Koopaei, R. Dinarvand, M. Amini, H. Rabbani, S. Emami, S.N. Ostad, and F. Atyabi Docetaxel immunonanocarriers as targeted delivery systems for HER 2-positive tumor cells: preparation, characterization, and cytotoxicity studies Int. J. Nanomed. 6 2011 1903 1912 10.2147/IJN.S23211
14. H. Kulhari, D. Pooja, S. Shrivastava, VGMN, and R. Sistla Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel Colloids. Surf. B. Biointerfaces 117 2014 166 173
15. S.A. Kulkarni, and S.-S. Feng Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier Nanomedicine 6 2011 377 394 10.2217/nnm.10.131
16. M.-K. Lee, S.-J. Lim, and C.-K. Kim Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles Biomaterials 28 2007 2137 2146 10.1016/j.biomaterials.2007.01.014
17. B. Magenheim, M.Y. Levy, and S. Benita A new in vitro technique for the evaluation of drug release profile from colloidal carriers - ultrafiltration technique at low pressure Int. J. Pharm. 94 1993 115 123 10.1016/0378-5173(93)90015-8
18. A. Montero, F. Fossella, G. Hortobagyi, and V. Valero Docetaxel for treatment of solid tumours: a systematic review of clinical data Lancet Oncol. 6 2005 229 239 10.1016/S1470-2045(05)70094-2
19. I.D. Morrison, and S. Ross Colloidal Dispersions: Suspensions, Emulsions, and Foams 1st ed. 2002 Wiley-Interscience New York
20. T. Musumeci, C.A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, R. Pignatello, and G. Puglisi PLA/PLGA nanoparticles for sustained release of docetaxel Int. J. Pharm. 325 2006 172 179
21. A.D. Ragin, R.A. Morgan, and J. Chmielewski Cellular import mediated by nuclear localization signal peptide sequences Chem. Biol. 9 2002 943 948
22. A. Rossi, P. Maione, G. Palazzolo, P.C. Sacco, M.L. Ferrara, M. Falanga, and C. Gridelli New targeted therapies and small-cell lung cancer Clin. Lung Cancer 9 2008 271 279
23. D.P. Ryan, M.H. Kulke, C.S. Fuchs, M.L. Grossbard, S.R. Grossman, J.A. Morgan, C.C. Earle, R. Shivdasani, H. Kim, R.J. Mayer, and J.W. Clark A phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma Cancer 94 2002 97 103
24. A. Sgambato, F. Casaluce, P. Maione, A. Rossi, P.C. Sacco, F. Panzone, F. Ciardiello, and C. Gridelli Medical treatment of small cell lung cancer: state of the art and new development Expert Opin. Pharmacother. 14 2013 2019 2031 10.1517/14656566.2013.823401
25. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA. Cancer J. Clin. 64 2014 9 29 10.3322/caac.21208
26. K. Siram, V.R. Chellan, T. Natarajan, B. Krishnamoorthy, H.R. Mohamed Ebrahim, V. Karanam, S.S.K. Muthuswamy, and H.P. Ranganathan Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation Expert Opin. Drug Deliv. 11 2014 1351 1365 10.1517/17425247.2014.915310
27. J.F. Smyth, I.E. Smith, C. Sessa, P. Schoffski, J. Wanders, H. Franklin, and S.B. Kaye Activity of docetaxel (Taxotere) in small cell lung cancer. The early clinical trials group of the EORTC Eur. J. Cancer 1990 30A 1994 1058 1060
28. B. Sun, and S.-S. Feng Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel Nanomedicine 4 2009 431 445 10.2217/nnm.09.17
29. F. Tavassolian, G. Kamalinia, H. Rouhani, M. Amini, S.N. Ostad, M.R. Khoshayand, F. Atyabi, M.R. Tehrani, and R. Dinarvand Targeted poly (L-(-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells Int. J. Pharm. 467 2014 123 138 10.1016/j.ijpharm.2014.03.033
30. A.T. Van Oosterom, D. Schrijvers, and D. Schrijvers Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: clinical experience Anticancer Drugs 6 1995 356 368
31. J. Wang, M. Sui, and W. Fan Nanoparticles for tumor targeted therapies and their pharmacokinetics Curr. Drug Metab. 11 2010 129 141
32. W.L. Watson, and J.W. Berg Oat cell lung cancer Cancer 15 1962 759 768
33. C. Wenzel, G.J. Locker, M. Schmidinger, M. Rudas, S. Taucher, M.F.X. Gnant, R. Jakesz, and G.G. Steger Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel + granulocyte colony stimulating factor Anticancer Drugs 13 2002 67 74
34. Z. Xu, L. Chen, W. Gu, Y. Gao, L. Lin, Z. Zhang, Y. Xi, and Y. Li The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma Biomaterials 30 2009 226 232
35. N. Yang, Y. Jiang, H. Zhang, B. Sun, C. Hou, J. Zheng, Y. Liu, and P. Zuo Active targeting docetaxel-PLA nanoparticles eradicate circulating lung cancer stem-like cells and inhibit liver metastasis Mol. Pharm. 12 2015 232 239 10.1021/mp500568z